Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 3/20 | 0.70 |
| ▸ | HTT | P42858 | 2/20 | 0.70 |
| ▸ | RAPGEF3 | O95398 | 11/20 | 0.65 |
| ▸ | RAPGEF4 | Q8WZA2 | 4/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 3/20 | 0.63 |
| ▸ | ALB | P02768 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9867790 | 1.00 | MAPT (0.70) | MAPTSMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL9868037 | 0.87 | MAPT (0.76) | MAPTSMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL9865909 | 0.87 | MAPT (0.76) | MAPTSMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL9868710 | 0.86 | MAPT (0.67) | MAPTSMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL9868712 | 0.86 | MAPT (0.67) | MAPTSMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL38652827 | 0.82 | MEN1 (0.64) | MAPTSMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL31597668 | 0.82 | MEN1 (0.64) | MAPTSMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL519291 | 0.80 | MAPT (0.72) | MAPTSMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL20523642 | 0.79 | RAPGEF3 (1.00) | MAPTSMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL9067633 | 0.79 | MAPT (0.70) | MAPTSMN1; SMN2MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150056160-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | TEXAS PHARMACEUTICALS, INC. | 2015-02-26 | — | — | US | claimed |
| EP-1098641-A4 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | ST JUDE PHARMACEUTICALS INC (US) | 2003-08-27 | — | — | EP | claimed |
| EP-1098641-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | Texas Pharmaceuticals, Inc. (US) | 2001-05-16 | — | — | EP | claimed |
| WO-2000006143-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | TEXAS PHARMACEUTICALS, INC. (US) | 2000-02-10 | — | — | WO | claimed |
| EP-1098641-B1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | ST JUDE PHARMACEUTICALS INC (US) | 2016-04-27 | — | — | EP | disclosed |
| US-20150056160-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | TEXAS PHARMACEUTICALS, INC. | 2015-02-26 | — | — | US | disclosed |
| US-20100056643-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | ST. JUDE PHARMACEUTICALS, INC. | 2010-03-04 | — | — | US | disclosed |
| US-7635722-B1 | Chemical induced intracellular hyperthermia | Saint Jude Pharmaceuticals, Inc. (US) | 2009-12-22 | — | — | US | disclosed |
| EP-1098641-A4 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | ST JUDE PHARMACEUTICALS INC (US) | 2003-08-27 | — | — | EP | disclosed |
| EP-1098641-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | Texas Pharmaceuticals, Inc. (US) | 2001-05-16 | — | — | EP | disclosed |
| WO-2000006143-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | TEXAS PHARMACEUTICALS, INC. (US) | 2000-02-10 | — | — | WO | disclosed |
| EP-0412211-A1 | Cancer therapy system | THERAPEUTICAL SYSTEMS CORPORATION (US) | 1991-02-13 | — | — | EP | disclosed |
| US-4935450-A | Cancer therapy system for effecting oncolysis of malignant neoplasms | THERAPEUTICAL SYSTEMS CORPORATION (US) | 1990-06-19 | — | — | US | disclosed |
| US-4724234-A | ADMINISTERING NUTRITIONAL REGIMEN AND AGENTS WHICH UNCOUPLE OXIDATIVE PHOSPHORYLATION | THERAPEUTICAL SYSTEMS CORP. (US) | 1988-02-09 | — | — | US | disclosed |